The CCL2/CCR2 axis is crucial for monocyte mobilization into the TME, and a myriad of preclinical mouse tumor models have proven this axis is both protumoral and targetable [180,203,210,213,215,442,443,444]. This evidence concerns the gene CCR2 and neoplasm.